Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) Active Not Recruiting Phase 2 Trials for Fludarabine (DB01073)

Also known as: Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)

IndicationStatusPhase
DBCOND0036073 (Adult Acute Myeloid Leukemia With T(8;21)(q22;q22))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00040846Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesTreatment
NCT00045435Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionTreatment
NCT00089011Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerTreatment